A multi-center NIH study initiated in 1997 is looking at acute liver failure and severe acute liver injury in adults. The aim of this study is to gather prospective demographic and clinical data on patients with acute liver failure and acute liver injury with varying etiologies.
Informed consent may be obtained from family member.
Blood and urine samples, clinical data, and survival will be obtained x 7 days.
Patients are invited for a return visit at 6 and 12 months to assess long-term outcomes. Participants will receive $30 for each return visit.
Contacts for referrals or questions: see below
Enrollment status: OPEN
The goal of the STOP-ALF protocol is to evaluate the safety and tolerability of OCR-002 (ornithine phenylacetate) to reduce venous ammonia levels in patients with ALF or severe liver injury due to acetaminophen overdose.
Principal investigator: Robert Fontana, MD firstname.lastname@example.org